Soleno Therapeutics Inc

Ownership Transactions Reported by 22 Insiders

Symbol
SLNO on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
100 Marine Parkway, Suite 400, Redwood City, CA

Insiders trading volume in the past year

Soleno Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Abingworth LLP 10%+ Owner $658M Dec 21, 2018
Vivo Opportunity, LLC 10%+ Owner $315M -$124M -28.3% Mar 26, 2025
Perceptive Advisors Llc 10%+ Owner $117M Sep 26, 2023
Carlyle Group Inc. 10%+ Owner $56.7M Sep 28, 2023
Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director $40M -$48.2M -54.7% Mar 27, 2025
James Mackaness Chief Financial Officer $7.45M -$6.65M -47.2% Mar 27, 2025
Meredith Manning Chief Commercial Officer $3.04M -$3.04M -50% Mar 27, 2025
Michael F. Huang Sr. VP of Clinical Development $2.58M -$1.01M -28.2% Mar 27, 2025
Kristen Yen Officer title: SVP Global Clinical Operations and Patient Advocacy $1.88M -$6.6M -77.8% Mar 27, 2025
William G. Harris Director $1.48M Jun 5, 2025
Birgitte Volck Director $1.34M Jun 5, 2025
Jack Schuler 10%+ Owner $1.34M Dec 9, 2022
Dawn Carter Bir Director $1.3M Jun 5, 2025
Patricia C. Hirano Officer title: Senior Vice President, Regulatory Affairs $1.09M -$11.5M -91.3% Jul 1, 2025
Manher Joshi Chief Development Officer $1.09M Nov 10, 2025
Kevin Norrett Chief Business Officer $990K Nov 17, 2025
Ernest Mario Director $967K Jun 6, 2024
Andrew Sinclair Director $800K Jun 5, 2025
Matthew Pauls Director $800K -$425K -34.7% Jun 5, 2025
Mark W. Hahn Director $679K Oct 13, 2025
Gwen A. Melincoff Director $24.3K May 25, 2023
Raymond W. Urbanski Chief Development Officer Aug 13, 2024

Recent Insider Transactions by Companies or Individuals for Soleno Therapeutics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.